Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA grants fast track status to DARA's KRN-5500

Aug. 19, 2011

New vitamin D analogues claimed

Aug. 19, 2011

Novel antitumor agents disclosed by Chinese and U.S. team

Aug. 19, 2011

New antitumor agents synthesized by Kyowa Hakko Kirin

Aug. 19, 2011

Dual FGF/VEGF pathway inhibitor shows promise in limiting tumor resistance to VEGF inhibition

Aug. 18, 2011

Roche obtains FDA approval for melanoma drug and companion diagnostic

Aug. 18, 2011

New prodrugs of proteasome inhibitors designed by Cephalon

Aug. 18, 2011

Allos Therapeutics begins phase III registration trial of Folotyn

Aug. 18, 2011

Emergent BioSolutions begins trial of TRU-016 in relapsed, indolent lymphoma

Aug. 18, 2011

Clavis reports interim results from phase II trial of elacytarabine/idarubicin combination

Aug. 17, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...